We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information for public health professionals on immunisation.
Guidance for organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA, covering the approval of paper documents when working from home
This Directorate Children and Young People (DCYP) COVID-19 page provides important advice and updates for service parents.
Guidance documents and updates for Sellafield Ltd employees.
How to get fast-track approval of medical devices during COVID-19.
Description of UKHSA adult surveillance programmes for COVID-19.
Advice and guidance for healthcare practitioners on the health needs of migrant patients.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Data on the real-world efficacy of the COVID-19 vaccines.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
Actions that trial sponsors should consider to build resilience into clinical trial design
A register of agreements relating to exclusion orders made by powers under paragraph 7 of Schedule 3 to The Competition Act 1998.
The HPV universal vaccination consent form for schools to distribute to parents of pupils.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
Guidance for industry on flexible approaches we are taking on good distribution practices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).